A six-year-old girl named Zara has become the first child in Australia to receive an infusion of her own stored cord blood as treatment for cerebral palsy outside of a clinical trial. Experts hope that this milestone will pave the way towards broader availability,...
Researchers are investigating a novel placenta-derived stem cell therapy for multiple sclerosis, a currently incurable degenerative neurological condition. A recent phase 1 clinical trial, with findings published in Scientific Reports, assessed the safety and...
A review paper, newly published in the prestigious Pediatrics journal, statistically demonstrates that cord blood therapy for cerebral palsy is an effective treatment to improve the motor skills of children suffering from this condition. The paper is an analysis of...
A new study on cell therapy for cerebral palsy has, for the first time, directly compared the efficacy of two different treatments. Although more research is needed, the study’s results offer valuable insights for future clinical trials tackling this challenging...
A recent study has found that a stem cell therapy could reduce epileptic symptoms after stroke and help the brain recover. The study was performed at the Gladstone Institute of Neurological Disease in California, USA, using a rat model of stroke. Stroke basics A...
The results reported from Phase II of the first FDA-approved trial for the treatment of multiple sclerosis (MS) using stem cells are highly promising, suggesting that stem cells could be a viable treatment option to help improve the lives of those with the condition....
Wharton’s Jelly Stem Cells Show Promise for Chronic Spinal Cord Injury in New Study
First Cord Blood Treatment for Cerebral Palsy Performed in Australia
Could Cord Tissue Stem Cells Help Manage Type 2 Diabetes?
Early Insights Into Placenta Stem Cell Therapy for Multiple Sclerosis
